Research Blogs

March 17, 2026

Three Moments That Defined the 2026 Targeted Therapies of Lung Cancer Conference

Read time: 3 minutes. The 2026 Targeted Therapies of Lung Cancer Meeting brought together leading clinicians, researchers, and patient advocates to discuss the latest advances

READ MORE about Three Moments That Defined the 2026 Targeted Therapies of Lung Cancer Conference›
February 24, 2026

Progress in Cancer Care: What the Numbers Tell Us About Lung Cancer

Read time: 3 minutes. Every January, the American Cancer Society releases a Cancer Facts & Figures report. It provides a clear view of where we stand in addressing cancer. The 2026

READ MORE about Progress in Cancer Care: What the Numbers Tell Us About Lung Cancer›
February 17, 2026

Your Voice Matters: Join the Citizen Scientists Improving Lung Cancer Research

Read time: 3 minutes. Research funders are increasingly calling on researchers to move beyond studying communities to actively involving them in the research process. They want

READ MORE about Your Voice Matters: Join the Citizen Scientists Improving Lung Cancer Research›
February 10, 2026

Artificial Intelligence in Lung Cancer: Hope vs. Hype

Read time: 2 minutes. Artificial intelligence (AI) is rapidly reshaping the future of cancer care, but such dramatic innovation also brings important questions. AI has evolved from

READ MORE about Artificial Intelligence in Lung Cancer: Hope vs. Hype›
February 03, 2026

Why Immunotherapy Isn’t Perfect & How Scientists Are Working to Fix It

Read time: 3 minutes. The human immune system is an intricate web of checks and balances that usually excels at detecting and destroying foreign invaders, such as bacteria and

READ MORE about Why Immunotherapy Isn’t Perfect & How Scientists Are Working to Fix It›
January 26, 2026

New Horizons in Immunotherapy: Lung Cancer Highlights from the 2025 SITC Meeting

Read time: 2 minutes. The Society for Immunotherapy of Cancer (SITC) celebrated their 40 th anniversary at their annual meeting in National Harbor, Maryland from November 5-9, 2025

READ MORE about New Horizons in Immunotherapy: Lung Cancer Highlights from the 2025 SITC Meeting›
January 20, 2026

Lung Cancer Lunch & Learn: Expert Insights on Research, Treatment, and Living Well

LUNGevity partnered with MD Anderson, UT Southwestern, and UT San Antonio to host panel discussions sharing valuable insights and helpful resources for people living with lung

READ MORE about Lung Cancer Lunch & Learn: Expert Insights on Research, Treatment, and Living Well›
January 13, 2026

The Future of Lung Cancer Starts Here

Read time: 1 minute. For more than two decades, LUNGevity Foundation has been a leader in advancing lung cancer research. Since 2002, we have invested $55+ million in more than 200

READ MORE about The Future of Lung Cancer Starts Here›
November 13, 2025

Uncovering Barriers to Timely Biomarker Testing in Cancer Care

Read time: 2 minutes. Comprehensive biomarker testing is one of the most powerful tools in modern lung cancer care, guiding treatment decisions and improving patient outcomes. Yet

READ MORE about Uncovering Barriers to Timely Biomarker Testing in Cancer Care›
November 12, 2025

Celebrating Progress in Lung Cancer: From Detection to Survivorship

Read time: 2 minutes. Over the past twenty years, lung cancer research and care have entered a new era. One filled with hope, innovation, and progress that is transforming what it

READ MORE about Celebrating Progress in Lung Cancer: From Detection to Survivorship›
October 09, 2025

Removing Obstacles to Drive Timely Precision Medicine for Patients

Read time: 3 minutes. Timely comprehensive biomarker testing has become the cornerstone of precision medicine in lung cancer care. For people diagnosed with non–small cell lung

READ MORE about Removing Obstacles to Drive Timely Precision Medicine for Patients›
October 02, 2025

Low-Dose Computed Tomography and Beyond: Advances in the Early Detection of Lung Cancer

Read time: 5 minutes. Lung cancer screening has come a long way since low-dose CT (LDCT) scans first became available in 2015 in the United States. However, LDCTs can still miss

READ MORE about Low-Dose Computed Tomography and Beyond: Advances in the Early Detection of Lung Cancer›